Summary: Cigna Healthcare modified its Vitamin D Testing coverage policy (policy 0526), effective April 25, 2026. Here's what billing teams need to know before claims hit the queue.
Vitamin D testing is one of the most commonly ordered—and most commonly denied—lab tests in outpatient billing. Cigna Healthcare, one of the largest commercial payers in the U.S., updated its Vitamin D testing coverage policy 0526 this month. If your practice orders routine Vitamin D panels or uses Vitamin D testing as part of chronic disease monitoring, this change deserves your attention now, not after a wave of claim denials lands in your work queue.
The policy document does not list specific CPT or HCPCS codes in the available data. You should pull the full policy text from Cigna directly and cross-reference your charge capture before the April 25, 2026 effective date passes.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Vitamin D Testing – Coverage Position Criteria (0526) |
| Policy Code | 0526 |
| Change Type | Modified |
| Effective Date | April 25, 2026 |
| Impact Level | High |
| Specialties Affected | Primary care, endocrinology, nephrology, oncology, rheumatology, OB/GYN, geriatrics |
| Key Action | Pull the full 0526 policy text, audit your Vitamin D testing indications against Cigna's updated medical necessity criteria, and update your denial management workflow before April 25, 2026 |
Cigna Vitamin D Testing Coverage Criteria and Medical Necessity Requirements 2026
Vitamin D testing sits in a difficult spot for payers. Clinical ordering volume exploded over the past decade, driven by broad awareness of deficiency risks. But commercial payers—Cigna included—have consistently pushed back by tightening medical necessity criteria to limit testing to patients with documented clinical indications.
Cigna's coverage policy 0526 governs when Vitamin D testing is considered medically necessary versus when it's treated as routine screening—and that distinction is everything for reimbursement. Routine screening in an otherwise healthy patient is almost always excluded. Testing tied to a specific diagnosis or clinical condition is where covered claims live.
The modified policy does not include specific CPT or HCPCS codes in the data available at publication. However, Vitamin D testing is typically billed under codes for 25-hydroxyvitamin D (the standard serum test) and 1,25-dihydroxyvitamin D (the active metabolite test, ordered less frequently). Your billing team should confirm which codes Cigna's updated 0526 policy explicitly addresses before the effective date of April 25, 2026.
Based on Cigna's longstanding coverage position on Vitamin D testing—and the pattern of policy modifications across commercial payers—this update likely refines the list of covered clinical indications. Expect tighter language around which diagnoses support medical necessity and which testing scenarios Cigna considers investigational or not covered. If your practice has not audited Vitamin D claims against Cigna's criteria recently, now is the time.
Prior authorization is not typically required for Vitamin D lab testing under commercial policies—but coverage hinges entirely on diagnosis coding. A claim for Vitamin D testing billed without a supported diagnosis code will generate a claim denial regardless of prior authorization status. That's the real exposure here.
Talk to your compliance officer if your practice orders Vitamin D testing at high volume across a mixed Cigna population. The financial exposure from systematic denial is real, and a proactive audit costs far less than a retroactive one.
Cigna Vitamin D Testing Exclusions and Non-Covered Indications
Cigna has historically treated several Vitamin D testing scenarios as not covered or investigational. These exclusions are where most claim denials originate.
Routine screening in patients without a documented clinical indication is the most common exclusion. If a patient has no symptoms, no chronic disease tied to Vitamin D metabolism, and no risk factors documented in the chart, Cigna typically denies the claim. Ordering providers who routinely add Vitamin D to wellness panels are generating non-covered claims.
Serial monitoring without a documented deficiency or condition also tends to fall outside coverage. Testing a patient every three months to "check levels" without a qualifying diagnosis is not the same as monitoring a patient with documented vitamin D deficiency on replacement therapy. Your documentation needs to reflect the clinical reason for each test ordered.
Testing for conditions Cigna considers investigational—where the clinical value of Vitamin D status has not been established—is another category to watch. This has historically included some cardiovascular risk assessment and broad cancer screening contexts. The updated 0526 policy may refine or expand this list.
Because the full modified policy text is not reproduced in the available data, confirm the exact exclusion language directly from Cigna's coverage policy documents or through the PayerPolicy platform before April 25, 2026.
Coverage Indications at a Glance
The policy data available does not include a detailed indication-level breakdown with specific covered and non-covered conditions from the modified 0526 document. The table below reflects Cigna's historically documented coverage positions on Vitamin D testing, which this update modifies. Verify each row against the full policy text before using this as a billing guide.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Documented Vitamin D deficiency or insufficiency | Likely Covered | Confirm with Cigna 0526 policy text | Diagnosis must be documented; confirm ICD-10 specificity |
| Malabsorption syndromes (e.g., Crohn's disease, celiac disease, bariatric surgery patients) | Likely Covered | Confirm with Cigna 0526 policy text | Clinical indication must be charted |
| Chronic kidney disease / renal osteodystrophy | Likely Covered | Confirm with Cigna 0526 policy text | Stage of CKD should be coded specifically |
| Osteoporosis or osteomalacia workup | Likely Covered | Confirm with Cigna 0526 policy text | Tie testing to bone disease diagnosis |
| Hypoparathyroidism or hyperparathyroidism | Likely Covered | Confirm with Cigna 0526 policy text | Document parathyroid condition in chart |
| Routine wellness screening in healthy adults | Not Covered | N/A | No qualifying diagnosis; consistent denial pattern |
| Serial monitoring without documented deficiency | Not Covered / Investigational | N/A | Frequency of testing must match clinical need |
| Investigational indications (e.g., cardiovascular risk, general cancer prevention) | Not Covered / Investigational | N/A | May be refined in updated 0526 language |
Important: This table is based on Cigna's general historical coverage position, not the specific text of the April 25, 2026 modification. Pull the updated 0526 policy and compare it line by line against your current indication list.
Cigna Vitamin D Testing Billing Guidelines and Action Items 2026
Vitamin D testing denials from Cigna are almost always diagnosis-driven. These action items are designed to cut your denial rate before the updated policy takes full effect.
| # | Action Item |
|---|---|
| 1 | Pull the full 0526 policy text immediately. Access Cigna Healthcare's updated coverage policy 0526 directly through Cigna's provider portal or the PayerPolicy platform. The modified policy is effective April 25, 2026. Read the coverage criteria section word for word—do not rely on a summary. |
| 2 | Audit your active Vitamin D orders against the updated criteria. Run a report of all Vitamin D testing claims billed to Cigna in the last 90 days. Flag any claims where the diagnosis code is vague, missing, or does not match a covered indication under the 0526 policy. This audit tells you where your current denial risk lives. |
| 3 | Update your ICD-10 documentation requirements at the point of order. Vitamin D testing reimbursement depends entirely on diagnosis specificity. Work with your ordering providers to make sure the chart supports the code before the test is ordered—not after a denial arrives. "Vitamin D deficiency" should be coded to the most specific ICD-10 code available, not to a general or unspecified code. |
| 4 | Review your standing order protocols for Vitamin D. If your practice uses standing orders or wellness panel templates that include Vitamin D as a routine add-on, those orders need to be evaluated against Cigna's updated criteria. Remove Vitamin D from panels where no covered indication exists for the patient population. This is not optional—routine screening without a covered diagnosis is a systematic denial generator. |
| 5 | Train your front-end billing team on the modified coverage policy. Update your denial management scripts so that when a Vitamin D claim denies under policy 0526, your team knows exactly what documentation to pull and what the appeal pathway looks like. A denial isn't a loss if your documentation is clean—but you need a workflow ready. |
| 6 | Check whether prior authorization is required under the updated policy. As noted above, prior authorization is not typical for lab testing, but confirm this against the modified 0526 language. If Cigna has added any prior auth requirements for specific indications or test frequencies, your team needs to know before orders go out. |
| 7 | Set a 30-day post-effective-date review. Pull your Cigna Vitamin D denial rate for claims processed after April 25, 2026, and compare it to your pre-change baseline. If denials increase, you have a documentation or indication-matching problem to solve quickly. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Vitamin D Testing Under Cigna Policy 0526
The updated Cigna policy 0526 data available at publication does not include a specific list of CPT, HCPCS, or ICD-10 codes. Do not use invented or assumed codes to build your billing workflows.
Here is what to do instead:
Pull the full policy document directly from Cigna's coverage policy library or through PayerPolicy's platform, which includes the line-by-line policy text and version history for 0526. The codes section of that document will list exactly which CPT codes Cigna applies this policy to—likely including codes for 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D serum testing.
Once you have the code list from the actual policy, cross-reference those codes against your charge master and your current claim volume by Cigna patients. That's the only way to size your financial exposure accurately.
If you need the full code table and cannot access the Cigna policy document before April 25, 2026, contact your Cigna provider relations representative and request the current version of coverage policy 0526 with all applicable codes listed.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.